Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02829944 · ClinicalTrials.gov registry record · Phase 4
Impact of Local Anesthetic Wound Infiltration on Postoperative Pain Following Cesarean Delivery
A Phase 4 study of Pain, sponsored by Duke University.
- Completed
- Registry status
- Phase 4
- Development phase
- 84
- Enrollment target
- 1
- Study location
NCT02829944: Completed Phase 4 study of Pain, sponsored by Duke University.
NCT02829944 is a Phase 4 study of Pain that has completed, run by Duke University. The registered enrollment target is 84 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (72% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02829944, a Phase 4 study of Pain, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 84 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine if the infusion of the local anesthetic ropivacaine (a numbing medicine) and the non-steroidal anti-inflammatory drug ketorolac (a pain killer similar to ibuprofen) through a catheter placed along the cesarean delivery incision, will reduce the pain experienced after cesarean section and need for narcotic pain medicine.
Primary Outcome
Score reported on a scale of 0-10, with 0 being none and 10 being the worst imaginable
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Ketorolac
- DRUG Ropivacaine
Study Locations (1)
North Carolina
- Duke University Hospital - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 84 participants |
| Start Date | 2016-11 |
| Est. Completion | 2019-09 |
| Phase | Phase 4 |
What the finished NCT02829944 record still lists
NCT02829944 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 84 participants, a relatively small participant target, below the 304-participant average among 374 other Pain trials with a reported enrollment target (72% lower).
The record links to 1 condition, with Pain appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.
NCT02829944 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT02829944 about?
NCT02829944 is a clinical study titled "Impact of Local Anesthetic Wound Infiltration on Postoperative Pain Following Cesarean Delivery". The purpose of this study is to determine if the infusion of the local anesthetic ropivacaine (a numbing medicine) and the non-steroidal anti-inflammatory drug ketorolac (a pain killer similar to ibuprofen) through a catheter placed along the cesarean delivery incision, will reduce the pain experien...
What is the current status of trial NCT02829944?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 84 participants. The study started on 2016-11. Estimated completion is 2019-09.
What conditions does trial NCT02829944 study?
This clinical trial studies the following conditions: Pain.
What interventions are being tested in trial NCT02829944?
The interventions under investigation include: Placebo (DRUG), Ketorolac (DRUG), Ropivacaine (DRUG).
Who is sponsoring clinical trial NCT02829944?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02829944 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02829944's enrollment target sits among peer trials
84 188th of 374 higher than 184 of 374 other Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effect of Magnesium on Neuromonitoring
RECRUITING · Phase 4
-
Low-Dose Ketamine Infusion During Burn Wound Care
RECRUITING · Phase 4
-
Optimizing Perioperative Analgesia to Lower Pain Following Cleft Palate Surgery
RECRUITING · Phase 4
-
Optimizing Pain Control in Transurethral Resection of the Prostate
RECRUITING · Phase 4
-
Low-dose Buccal Buprenorphine: Relative Abuse Potential and Analgesia
RECRUITING · Phase 4
-
Regional Blocks for Lateral Condyle Fractures
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02391519 · 84 participants
Effects of High Altitude on AMPK Activation
- NCT03838536 · 84 participants · NA
Synergistic Activity of Human Milk Nutrients and Infant Cognition
- NCT03884075 · 84 participants · Phase 2
Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)
- NCT03894917 · 84 participants
Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular Carcinoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia